DENVER, CO--(NewMediaWire - May 17, 2016) - American
Cannabis Company, Inc. (OTCQB: AMMJ) (the "Company"), a full-service
business-to-business consulting solutions provider, and seller of
ancillary products to the cannabis industry, today announced that
its Florida client has purchased a Cultivation Cube.
American Cannabis Company's Cultivation Cube™ is a completely
self-contained grow solution retrofitted into a 40' shipping
container. Controlling all grow variables, this self-contained
unit provides an ideal environment for phyto-pharmaceutical
cannabis production. The Cultivation Cube™ also allows for 40% more
lights per 1000 square feet and further space optimization with the
ability to stack the Cultivation Cube™. Finally, it provides a
growing operation that delivers greater speed-to-market, better
risk mitigation, increased production and lean manufacturing
efficiencies.
Corey Hollister, president and CEO of American Cannabis Company,
commented: "We are very excited that this solution provided the
right fit for our client. The Cultivation Cube has become one of
multiple facility design solutions we have developed, but is still
unmatched for achieving speed-to-market among other unique benefits
and resources."
About American Cannabis Company, Inc.:
American Cannabis Company, Inc. offers end-to-end solutions to
existing and aspiring participants in the cannabis industry. We
utilize our industry expertise to provide business planning and
market assessment services, assist state licensing procurement,
create business infrastructure and operational best practices.
Through our two vertically integrated businesses, American Cannabis
Consulting and American Cultivator Company, a group purchasing
organization, we support our clients from concept to creation to
commercialization to on-going operations.
For more information, please visit: www.americancannabiscompanyinc.com.
Forward Looking Statements
This news release contains "forward-looking statements" which are
not purely historical and may include any statements regarding
beliefs, plans, expectations or intentions regarding the future.
Such forward-looking statements include, among other things, the
development, costs and results of new business opportunities and
words such as "anticipate", "seek", intend", "believe", "estimate",
"expect", "project", "plan", or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Actual results could
differ from those projected in any forward-looking statements due
to numerous factors. Such factors include, among others, the
inherent uncertainties associated with new projects, the future
U.S. and global economies, the impact of competition, and the
Company's reliance on existing regulations regarding the use and
development of cannabis-based drugs. These forward-looking
statements are made as of the date of this news release, and we
assume no obligation to update the forward-looking statements, or
to update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe
that any beliefs, plans, expectations and intentions contained in
this press release are reasonable, there can be no assurance that
any such beliefs, plans, expectations or intentions will prove to
be accurate. Investors should consult all of the information set
forth herein and should also refer to the risk factors disclosure
outlined in our annual report on Form 10-K for the most recent
fiscal year, our quarterly reports on Form 10-Q and other periodic
reports filed from time-to-time with the Securities and Exchange
Commission. For more information, please visit www.sec.gov.